Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H18F3NO |
| Molecular Weight | 273.294 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N1CCOC(C1)C2=CC=CC(=C2)C(F)(F)F
InChI
InChIKey=FVYUQFQCEOZYHZ-UHFFFAOYSA-N
InChI=1S/C14H18F3NO/c1-10(2)18-6-7-19-13(9-18)11-4-3-5-12(8-11)14(15,16)17/h3-5,8,10,13H,6-7,9H2,1-2H3
| Molecular Formula | C14H18F3NO |
| Molecular Weight | 273.294 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Oxaflozane is non-tricyclic antidepressant with serotoninergic action. In animals, oxaflozane has anti-cataleptic and anti-aggressive action with weak potentiation of stereotypes provoked by amphetamine. Oxaflozane was developed by Solvay Pharma and marketed in France under tradename Conflictan. The drug was discontinued in 2004.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:29:57 GMT 2025
by
admin
on
Mon Mar 31 19:29:57 GMT 2025
|
| Record UNII |
V4WLW77V5Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
N06AX10
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
||
|
WHO-VATC |
QN06AX10
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
26629-87-8
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
3044
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
m861
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
C75175
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
2007
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106996
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
C005357
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
SUB09486MIG
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
V4WLW77V5Q
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
247-855-8
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
100000083559
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
DB13457
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
432824
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
DTXSID50865308
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
